Biografisk notat

Dr. Boffetta moved to Mount Sinai School of Medicine in 2010. He is Associate Director for Population Sciences of The Tisch Cancer Institute and Chief of the Division of Cancer Prevention and Control of the Department of Oncological Sciences. He is also the Bluhdorn Professor of International Community Medicine. Dr. Boffetta is Adjunct Professor at the Harvard School of Public Health (Boston, MA), Vanderbilt University (Nashville, TN), and the Catholic University of Rome (Italy). He is also Affiliate Member of the R. Samuel McLaughlin Centre for Population Health Risk Assessment, University of Ottawa (Ottawa, Canada), and Senior Fellow of the Hellenic Health Foundation (Athens, Greece). H-index 99; 1134 documents; publication range 1987 – present; over 150 co-authors; 42,863 citations in 29,080 documents Pierre Hainaut (born 1958, Belgium) is PhD in Biology, University of Liège, Belgium, 1987. After postdocs in France and in the UK (1988-1994), he joined the International Agency for Research on Cancer (IARC, World Health Organization) in 1994, where he held the post of head of Molecular Carcinogenesis from 1999 to 2011. In 2012, he joined the International Prevention Research Institute as Research Director. Since 2014, has been appointed as Professor of Cancer Biology and Chair of Excellence in Translational Research at Université Grenoble Alpes, France. Since October 2014, he is Director of the Institute of Advanced Biosciences (formerly Institut Albert Bonniot), a multi-thematic research center supported dedicated to Epigenetics, Chronic Diseases and Cancer (17 research teams). His research focuses on TP53 mutations and on biomarkers of transition from chronic diseases to cancer. From 1994 to 2011, he has led the development of the international IARC database of TP53 mutations, a source of information on the causes and consequences of mutations affecting the p53 suppressor protein in cancer. His current research focuses on gain-of-function effects in lung cancer and on biomarkers for early detection of liver and lung cancers, in particular in low-resource countries. Pierre Hainaut is author of over 400 publications and 50 book chapters (h index: 72, Google Scholar). He has co-edited two books on p53 (“25 Years of p53 Research” 2005, 2007, “p53 in the Clinics”, Springer) and a textbook of Molecular Epidemiology (“Molecular Epidemiology: Principle and Practice”, IARC Press, 2011).